Integra LifeSciences (IART) Competitors

Integer (NYSE:ITGR) and Integra LifeSciences (NASDAQ:IART) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation, media sentiment and analyst recommendations.

Do insiders & institutionals believe in ITGR or IART?

99.3% of Integer shares are owned by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are owned by institutional investors. 2.2% of Integer shares are owned by company insiders. Comparatively, 3.5% of Integra LifeSciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Is ITGR or IART more profitable?

Integer has a net margin of 4.61% compared to Integra LifeSciences' net margin of -30.87%. Integer's return on equity of 12.27% beat Integra LifeSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	4.61%	12.27%	6.23%
Integra LifeSciences	-30.87%	12.15%	4.32%

Do analysts recommend ITGR or IART?

Integer currently has a consensus target price of $140.25, indicating a potential upside of 30.37%. Integra LifeSciences has a consensus target price of $18.43, indicating a potential upside of 21.80%. Given Integer's stronger consensus rating and higher probable upside, research analysts plainly believe Integer is more favorable than Integra LifeSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	3.00
Integra LifeSciences	4 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.78

Which has higher earnings and valuation, ITGR or IART?

Integer has higher revenue and earnings than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.72B	2.20	$119.90M	$2.27	47.39
Integra LifeSciences	$1.62B	0.73	-$6.94M	-$6.53	-2.32

Which has more risk and volatility, ITGR or IART?

Integer has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500. Comparatively, Integra LifeSciences has a beta of 1.16, suggesting that its stock price is 16% more volatile than the S&P 500.

Does the media prefer ITGR or IART?

In the previous week, Integra LifeSciences had 4 more articles in the media than Integer. MarketBeat recorded 10 mentions for Integra LifeSciences and 6 mentions for Integer. Integer's average media sentiment score of 1.66 beat Integra LifeSciences' score of 1.40 indicating that Integer is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	6 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Integra LifeSciences	6 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Integer beats Integra LifeSciences on 14 of the 17 factors compared between the two stocks.